GOLETA, CA - (UCSB)- University of California Santa Barbara in collaboration with the Centers for Disease Control and Prevention (CDC) will offer a two-week meningitis B vaccination clinic beginning on Monday, February 24 for the first of the two recommended doses. Both doses of the vaccination will be provided at no cost to recipients.
Though the campus has not had any additional cases of meningitis since late November, the CDC is recommending the vaccine for certain populations to help protect the community against meningococcal disease. Specified groups were recommended by the CDC to receive the vaccine because young adults and people with certain medical conditions are at increased risk of getting meningococcal disease, especially those who live in close quarters, such as dormitory-style residence halls. Details about the clinic and those eligible to receive the vaccine are available at http://studenthealth.sa.ucsb.edu/FAQsMeningBVaccine.aspx.
Even if students have already received a meningococcal vaccine (Menactra or Menveo), they are not currently protected against the serogroup B bacteria. The vaccine recommended by the CDC offers protection against the specific strain involved in the outbreak at the University.
The first dose of the vaccine will be available at the MAC (Multi-Activity Court) at the Recreation Center (RecCen) for two weeks at the following times:
Monday, February 24 12 p.m. to 6 p.m.
Tuesday, February 25 – Friday, February 28 10 a.m. to 6 p.m.
Monday, March 3 – Friday, March 7 10 a.m. to 6 p.m.
Though not yet licensed in the United States, the vaccine has been approved by the Food and Drug Administration for use to help control the outbreak at the University. Detailed information about the vaccine, including information about its safety, is available at http://www.cdc.gov/meningococcal/outbreaks/vaccine-serogroupB.html and at http://studenthealth.sa.ucsb.edu/technicalfaqscdc.aspx.